{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:14:46Z","timestamp":1786947286822,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.japh.2022.05.011","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:54:27Z","timestamp":1652795667000},"page":"1707-1710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-1018","authenticated-orcid":false,"given":"Kristin","family":"Waters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5198-5992","authenticated-orcid":false,"given":"Ashley","family":"Tewksbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2022.05.011_bib2","series-title":"Wide-Ranging Online Data for Epidemiologic Research (WONDER)","year":"2020"},{"key":"10.1016\/j.japh.2022.05.011_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.japh.2022.05.011_bib5","first-page":"33","article-title":"Urine drug tests: ordering and interpretation","volume":"99","author":"Kale","year":"2019","journal-title":"Am Fam Physician"},{"issue":"1_suppl","key":"10.1016\/j.japh.2022.05.011_bib6","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1177\/00333549211042834","article-title":"Biosurveillance of drug overdoses and substance misuse treated in selected emergency department in Minnesota, 2017-2020","volume":"136","author":"Weins","year":"2021","journal-title":"Public Health Rep"},{"key":"10.1016\/j.japh.2022.05.011_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance","volume":"46","author":"Slavova","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.japh.2022.05.011_bib8","first-page":"150","article-title":"Non-prescription fentanyl positive toxicology: prevalence, positive predictive value of fentanyl immunoassay screening, and description of co-substance use","volume":"15","author":"Kerensky","year":"2021","journal-title":"J\u00a0Addict Med"},{"issue":"23","key":"10.1016\/j.japh.2022.05.011_bib10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6923a3","article-title":"Notes from the field: high prevalence of fentanyl detected by the Maryland Emergency Drug Surveillance System-Baltimore, Maryland, 2019","volume":"69","author":"Dezman","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.japh.2022.05.011_bib11","doi-asserted-by":"crossref","first-page":"239e245","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.japh.2022.05.011_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jat\/bkz019","article-title":"False-positive serum cocaine screening results in patients undergoing evaluation for renal transplant","volume":"43","author":"Snozek","year":"2019","journal-title":"J\u00a0Anal Toxicol"},{"issue":"1","key":"10.1016\/j.japh.2022.05.011_bib13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/TP.0b013e3181fc8903","article-title":"Impact of substance abuse on access to renal transplantation","volume":"91","author":"Sandhu","year":"2011","journal-title":"Trasplantation"},{"issue":"3","key":"10.1016\/j.japh.2022.05.011_bib14","article-title":"Urinary drug testing in pain management","volume":"5","author":"Florete","year":"2018","journal-title":"Pract Pain Manag"},{"issue":"6","key":"10.1016\/j.japh.2022.05.011_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5055\/jom.2015.0303","article-title":"History of drug use predicts opioid treatment agreement violation","volume":"11","author":"Summers","year":"2015","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.japh.2022.05.011_bib16","doi-asserted-by":"crossref","first-page":"108155","DOI":"10.1016\/j.jsat.2020.108155","article-title":"Down the drain: reconsidering routine urine drug testing during the COVID-19 pandemic","volume":"120","author":"Pytell","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.japh.2022.05.011_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/appi.ps.51.4.474","article-title":"Utility of routine drug screening in a psychiatric emergency setting","volume":"51","author":"Schiller","year":"2000","journal-title":"Psychiatr Serv"},{"issue":"4","key":"10.1016\/j.japh.2022.05.011_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/15563650902907798","article-title":"Do you really need that emergency drug screen?","volume":"47","author":"Tenebein","year":"2009","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.japh.2022.05.011_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1039856214568213","article-title":"Use of the urine drug screen in psychiatry emergency service","volume":"23","author":"Akosile","year":"2015","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.japh.2022.05.011_bib20","article-title":"Assessing the utility of drug screening in the emergency: a short report","volume":"7","author":"Bahji","year":"2019","journal-title":"BMJ Open Qual"},{"issue":"3","key":"10.1016\/j.japh.2022.05.011_bib21","first-page":"163","article-title":"Appropriate use of drug testing in clinical addiction medicine","volume":"11","author":"Jarvis","year":"2017","journal-title":"J\u00a0Addict Med"},{"issue":"9","key":"10.1016\/j.japh.2022.05.011_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jat\/bku103","article-title":"Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay","volume":"38","author":"Wang","year":"2014","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.japh.2022.05.011_bib23","doi-asserted-by":"crossref","first-page":"114246","DOI":"10.1016\/j.psychres.2021.114246","article-title":"False-positive fentanyl screening kit results during treatment with long term injectable risperidone (Risperdal-Consta)","volume":"305","author":"Shroitman","year":"2021","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.japh.2022.05.011_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/20961790.2019.1588933","article-title":"Novel synthetic opioids-toxicological aspects and analysis","volume":"4","author":"Tabarra","year":"2019","journal-title":"Forensic Sci Res"},{"key":"10.1016\/j.japh.2022.05.011_bib25","series-title":"Ziprasidone [Package Insert]","year":"2000"},{"key":"10.1016\/j.japh.2022.05.011_bib26","series-title":"Synthesis of Best-Seller Drugs","author":"Vardanyan","year":"2016"},{"key":"10.1016\/j.japh.2022.05.011_bib27","series-title":"Thermo Scientific DRI Fentanyl Assay [Package Insert]","year":"2018"},{"issue":"5","key":"10.1016\/j.japh.2022.05.011_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens","volume":"92","author":"Moeller","year":"2017","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:51:20Z","timestamp":1761544280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1544319122001492"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.05.011","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}